Navigation Links
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
Date:7/19/2009

ownload any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies, and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit GlaxoSmithKline on the World Wide Web at www.gsk.com.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) for lupus. Albuferon has now completed Phase 3 development, and the submission of global marketing applications is expected in fall 2009. BENLYSTA successfully met its primary endpoint in the first of two Phase 3 trials in systemic lupus erythematosus; results of the second BENLYSTA Phase 3 trial are expected in November 2009. Also in late-stage development is raxibacumab (ABthrax(TM)) for the treatment of inhalation anthrax (Biologics License Application currently pending with the U.S. Food and Drug Administration). In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria(R) (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.

For more information about HGS, please
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
(Date:8/29/2014)... August 29, 2014 According ... Market by Extraction type (SFE, Cold Pressed, Organic ... Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - Global ... defines and segments the Amaranth Seed Oil Market ... size in terms of value. The Amaranth Seed ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Research and Development Trend Forecast of Pharmaceutical Equipment ... Research and Development Trend Forecast of ... 2014-2018 mainly analyzes China,s pharmaceutical ... supply & demand, competition landscape, and business performance of ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... In today,s payer-driven market, managed care formulary access is ... isn,t an end unto itself. In addition to formulary ... to effective pull-through programs and processes to increase market ... help organizations create and maintain effective pull-through programs and ...
... BEIJING, Nov. 12, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems ... "Company"), an emerging leader in the development, assembly, marketing ... in China, today announced its financial results for the ... revenues of $5.5 million and quarterly GAAP net income ...
Cached Medicine Technology:Creating a Platform for Managed Care Pull-Through Success in 2011 2Dehaier Medical Announces Third Quarter 2010 Financial Results 2Dehaier Medical Announces Third Quarter 2010 Financial Results 3Dehaier Medical Announces Third Quarter 2010 Financial Results 4Dehaier Medical Announces Third Quarter 2010 Financial Results 5Dehaier Medical Announces Third Quarter 2010 Financial Results 6Dehaier Medical Announces Third Quarter 2010 Financial Results 7Dehaier Medical Announces Third Quarter 2010 Financial Results 8Dehaier Medical Announces Third Quarter 2010 Financial Results 9
(Date:8/31/2014)... Memphis, TN (PRWEB) August 31, 2014 ... for ambulance safes and narcotics lockers ... to offer the MedixSafe brand for distribution worldwide. “We ... United Arab Emirates.” Lindsay McCollum, MedixSafe Sales Manager , ... Memphis based, electronic security and network cabling company with ...
(Date:8/31/2014)... 01, 2014 Recently, BambooIndustry.com, one of the ... with a new selection of bamboo veneers . Additionally, ... percent off) for these high quality products. The promotion will ... senior spokesman says that its top quality veneers are hot ... the new designs of bamboo veneers. All these items are ...
(Date:8/31/2014)... With years of hard work, Delta has now become ... Recently, the company has updated its wheel loader ... All these items are guaranteed to be great. Additionally, they ... It is true that all items in Delta’s used ... specialists. The firm is making full efforts to help worldwide ...
(Date:8/31/2014)... August 31, 2014 Asked to ... difference between "Bioavailability" and "absorption," Dr. Priya Khan, ... with great interest. "Bioavailability" and "absorption" are ... in the supplement industry, second perhaps only to ... Bioavailability and absorption, while related, are not the ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 Ticket Down ... Bolivia tickets at Dick’s Sporting Goods Park in suburban ... a plethora of games against other international teams on USA ... Cup, Mexico brought a new soccer coach aboard, Miguel Herrera, ... In the build-up before the World Cup in Brazil, the ...
Breaking Medicine News(10 mins):Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 2Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 3Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 3Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 4Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 3
... process carbohydrates more slowly, expert says , MONDAY, April 12 ... quickly transformed into sugar in the blood raises the risk ... , The same effect, however, is not seen in men, ... Archives of Internal Medicine . , The study, by researchers ...
... April 12, 2010 A strategic alliance announced ... Limited will significant advance personalized medicine. The partnership ... companies to more rationally design and tailor their drugs ... variations that define a given disease. TD2 will ...
... lower esophagus develops almost exclusively in patients with ... reflux that affects approximately 3 million Americans. Although ... is poor, the chances of successful treatment increase ... early dysplastic stage. Now, a new endoscopic ...
... gynecologic surgery to address noncancerous symptoms said in a recently ... of the procedure on their sex lives. However, a ... express concern in this study that they might have less ... does not affect hormone levels. Among those in the ...
... tougher to get colonoscopies, study finds , MONDAY, April 12 ... are harder to find in areas of the United States ... could help explain why Hispanics are less likely to get ... group led by Dr. Jennifer Haas of Brigham and Women,s ...
... 10,000 women with early breast cancer has found wide variations ... practice, according to the May issue of the British ... Japan and America compared 9,779 women with an average age ... Greece, Japan, the Netherlands, the UK/Ireland and the USA. ...
Cached Medicine News:Health News:Simple Carbs Pose Heart Risk for Women 2Health News:Simple Carbs Pose Heart Risk for Women 3Health News:TGen Drug Development partners with Horizon Discovery for integrated personalized medicine service 2Health News:New form of endoscopic scanning improves detection of precancerous condition 2Health News:New form of endoscopic scanning improves detection of precancerous condition 3Health News:Most women facing gynecologic surgery don't worry about its effects on sex 2Health News:Most women facing gynecologic surgery don't worry about its effects on sex 3Health News:Most women facing gynecologic surgery don't worry about its effects on sex 4Health News:9-country study shows wide variations in how women with early breast cancer are treated 2
Stylish, comfortable and attractive, the new Keeler Sport frame is available in a choice of bright colors. The Keeler Sport frame can be worn over your own glasses, or your prescription can be incorp...
... the finest operating room stool available today. This ... surgeon who must remain absolutely steady for long ... shift resulting in unanticipated hand motion. The Machemer ... casters. A "foot bar" allows the surgeon to ...
This is a 2.5x focusing Galilean telescope with a range from 70cm to infinity. Ideal for use at sporting events, as well as for a wide range of hobbies....
This 6x or 8x aspheric magnifier is fitted with a distance piece and is particularly useful for patients with tremor or focusing difficulties. The magnifier can be either spectacle mounted or hand h...
Medicine Products: